Log in

NASDAQ:SUPNSupernus Pharmaceuticals SEC Filings & 10K Form

$24.01
-0.23 (-0.95 %)
(As of 05/22/2020 04:00 PM ET)
Add
Compare
Today's Range
$23.29
Now: $24.01
$24.43
50-Day Range
$17.09
MA: $20.68
$24.24
52-Week Range
$13.12
Now: $24.01
$34.11
Volume559,643 shs
Average Volume571,447 shs
Market Capitalization$1.26 billion
P/E Ratio11.06
Dividend YieldN/A
Beta1.61

SEC Filings

Supernus Pharmaceuticals (NASDAQ:SUPN) SEC Filings

DateFilerForm TypeView
05/20/2020
5:59 PM
PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2020
1:14 PM
Supernus Pharmaceuticals (Filer)
Form NT 10-Q
05/11/2020
5:42 PM
PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2020
3:52 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2020
11:00 AM
Supernus Pharmaceuticals (Filer)
Form DEFA14A
04/24/2020
8:27 AM
Supernus Pharmaceuticals (Filer)
Form DEFA14A
04/24/2020
8:26 AM
Supernus Pharmaceuticals (Filer)
Form DEF 14A
03/23/2020
7:36 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2020
4:13 PM
ARMISTICE CAPITAL, LLC (Filed by)
Supernus Pharmaceuticals (Subject)
Form SC 13G
02/28/2020
12:05 PM
Supernus Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2020
5:51 PM
Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2020
5:40 PM
Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/25/2020
5:33 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2020
5:31 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/25/2020
4:59 PM
NEWHALL CHARLES W III (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
3:36 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2020
10:07 AM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2019
3:02 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
3:12 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2019
1:59 PM
Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
4:14 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2019
3:04 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2019
3:29 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2019
4:27 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2019
11:25 AM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
10:02 AM
Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
3:57 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2019
4:28 PM
PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2019
4:20 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2019
7:06 PM
SIEBERT JOHN M (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
3:29 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
3:18 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
2:38 PM
Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
4:30 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2019
3:12 PM
Supernus Pharmaceuticals (Filer)
Form DEF 14A
04/29/2019
2:43 PM
SIEBERT JOHN M (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2019
4:33 PM
Matushansky Igor (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2019
4:33 PM
Pinschewer David (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2019
4:32 PM
Lengauer Christoph (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2019
3:46 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2019
3:34 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2019
3:42 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2019
4:19 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
3:29 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
4:52 PM
SIEBERT JOHN M (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4/A
03/04/2019
4:41 PM
SIEBERT JOHN M (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
12:57 PM
Supernus Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2019
3:29 PM
PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
6:28 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
6:28 PM
Schwabe Stefan K.F. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
6:27 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
6:27 PM
PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
6:26 PM
Hudson Frederick M. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
6:25 PM
GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
6:25 PM
Barlow Carrolee (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
6:25 PM
NEWHALL CHARLES W III (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
6:24 PM
SIEBERT JOHN M (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
5:59 PM
PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/26/2019
4:18 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2019
4:03 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2019
10:06 AM
BlackRock Inc. (Filed by)
Supernus Pharmaceuticals (Subject)
Form SC 13G/A
02/05/2019
3:33 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2019
5:04 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2019
4:10 PM
Supernus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
12/21/2018
3:37 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2018
3:41 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2018
4:17 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/30/2018
9:32 AM
Supernus Pharmaceuticals (Filer)
Form CT ORDER
11/09/2018
8:49 AM
Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2018
3:38 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2018
3:58 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2018
3:54 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2018
1:32 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2018
7:20 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2018
4:11 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2018
2:17 PM
Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2018
4:30 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/27/2018
4:21 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2018
2:27 PM
PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2018
4:52 PM
Barlow Carrolee (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2018
4:46 PM
Barlow Carrolee (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/02/2018
4:21 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2018
5:03 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2018
4:30 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2018
4:51 PM
Schwabe Stefan K.F. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2018
3:10 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2018
3:31 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2018
4:05 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2018
2:09 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2018
2:24 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2018
12:57 PM
Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2018
4:17 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2018
4:26 PM
Supernus Pharmaceuticals (Filer)
Form DEF 14A
04/25/2018
3:33 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2018
3:53 PM
Supernus Pharmaceuticals (Issuer)
Vaughn Victor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2018
11:12 AM
Supernus Pharmaceuticals (Issuer)
Vaughn Victor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2018
4:12 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2018
3:12 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2018
2:25 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2018
3:33 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 5/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.